References
- Jang WI, Kim MS, Bae SH, et al. High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma. Radiat Oncol 2013;8:250. https://doi.org/10.1186/1748-717X-8-250
- Nagata Y. Stereotactic body radiotherapy for early stage lung cancer. Cancer Res Treat 2013;45:155-61. https://doi.org/10.4143/crt.2013.45.3.155
- Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-6. https://doi.org/10.1001/jama.2010.261
- Cho LC, Fonteyne V, DeNeve W, Lo SS, Timmerman RD. Stereotactic body radiotherapy. In: Levitt SH, Purdy JA, Perez CA, Poortmans P, editors. Technical basis of radiation therapy: practical clinical applications. 5th ed. New York, NY: Springer; 2012. p. 363-400.
- Staehler M, Bader M, Schlenker B, et al. Single fraction radiosurgery for the treatment of renal tumors. J Urol 2015; 193:771-5. https://doi.org/10.1016/j.juro.2014.08.044
- Kim YJ, Cho KH, Kim JY, et al. Single-dose versus fractionated stereotactic radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 2011;81:483-9. https://doi.org/10.1016/j.ijrobp.2010.05.033
- Song CW, Park H, Griffin RJ, Levitt SH. Radiobiology of stereotactic radiosurgery and stereotactic body radiation therapy. In: Levitt SH, Purdy JA, Perez CA, Poortmans P, editors. Technical basis of radiation therapy: practical clinical applications. 5th ed. New York, NY: Springer; 2012. p. 51-61.
- Song CW, Kim MS, Cho LC, Dusenbery K, Sperduto PW. Radiobiological basis of SBRT and SRS. Int J Clin Oncol 2014; 19:570-8. https://doi.org/10.1007/s10147-014-0717-z
- Brown JM, Carlson DJ, Brenner DJ. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int J Radiat Oncol Biol Phys 2014;88:254-62. https://doi.org/10.1016/j.ijrobp.2013.07.022
- Song CW, Cho LC, Yuan J, Dusenbery KE, Griffin RJ, Levitt SH. Radiobiology of stereotactic body radiation therapy/ stereotactic radiosurgery and the linear-quadratic model. Int J Radiat Oncol Biol Phys 2013;87:18-9. https://doi.org/10.1016/j.ijrobp.2013.03.013
- Song CW, Park I, Cho LC, et al. Is indirect cell death involved in response of tumors to stereotactic radiosurgery and stereotactic body radiation therapy? Int J Radiat Oncol Biol Phys 2014;89:924-5. https://doi.org/10.1016/j.ijrobp.2014.03.043
- Sperduto PW, Song CW, Kirkpatrick JP, Glatstein E. A hypothesis: indirect cell death in the radiosurgery era. Int J Radiat Oncol Biol Phys 2015;91:11-3. https://doi.org/10.1016/j.ijrobp.2014.08.355
- Song CW, Lee YJ, Griffin RJ, et al. Indirect tumor cell death after high-dose hypofractionated irradiation: implications for stereotactic body radiation therapy and stereotactic radiation surgery. Int J Radiat Oncol Biol Phys 2015;93:166-72. https://doi.org/10.1016/j.ijrobp.2015.05.016
- Kocher M, Treuer H, Voges J, Hoevels M, Sturm V, Muller RP. Computer simulation of cytotoxic and vascular effects of radiosurgery in solid and necrotic brain metastases. Radiother Oncol 2000;54:149-56. https://doi.org/10.1016/S0167-8140(99)00168-1
- Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW. Radiationinduced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res 2012;177:311-27. https://doi.org/10.1667/RR2773.1
- Del Monte U. Does the cell number 10(9) still really fit one gram of tumor tissue? Cell Cycle 2009;8:505-6. https://doi.org/10.4161/cc.8.3.7608
- Clement JJ, Tanaka N, Song CW. Tumor reoxygenation and postirradiation vascular changes. Radiology 1978;127:799-803. https://doi.org/10.1148/127.3.799
- Leith JT, Cook S, Chougule P, et al. Intrinsic and extrinsic characteristics of human tumors relevant to radiosurgery: comparative cellular radiosensitivity and hypoxic percentages. Acta Neurochir Suppl 1994;62:18-27. https://doi.org/10.1007/978-3-7091-9371-6_5
- Brown JM, Diehn M, Loo BW Jr. Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys 2010;78:323-7. https://doi.org/10.1016/j.ijrobp.2010.04.070
- Pasqualini R, Arap W, McDonald DM. Probing the structural and molecular diversity of tumor vasculature. Trends Mol Med 2002;8:563-71. https://doi.org/10.1016/S1471-4914(02)02429-2
- Song CW, Levitt SH. Quantitative study of vascularity in Walker carcinoma 256. Cancer Res 1971;31:587-9.
- Clement JJ, Song CW, Levitt SH. Changes in functional vascularity and cell number following x-irradiation of a murine carcinoma. Int J Radiat Oncol Biol Phys 1976;1:671-8. https://doi.org/10.1016/0360-3016(76)90149-8
- Song CW, Levitt SH. Effect of x irradiation on vascularity of normal tissues and experimental tumor. Radiology 1970;94: 445-7. https://doi.org/10.1148/94.2.445
- Song CW, Levitt SH. Vascular changes in Walker 256 carcinoma of rats following X irradiation. Radiology 1971;100:397-407. https://doi.org/10.1148/100.2.397
- Wong HH, Song CW, Levitt SH. Early changes in the functional vasculature of Walker carcinoma 256 following irradiation. Radiology 1973;108:429-34. https://doi.org/10.1148/108.2.429
- Song CW, Sung JH, Clement JJ, Levitt SH. Vascular changes in neuroblastoma of mice following x-irradiation. Cancer Res 1974;34:2344-50.
- Emami B, Ten Haken RK, Nussbaum GH, Hughes WL. Effects of single-dose irradiation in tumor blood flow studied by 15O decay after proton activation in situ. Radiology 1981;141:207-9. https://doi.org/10.1148/radiology.141.1.7291527
- Brown SL, Nagaraja TN, Aryal MP, et al. MRI-tracked tumor vascular changes in the hours after single-fraction irradiation. Radiat Res 2015;183:713-21. https://doi.org/10.1667/RR13458.1
- Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003;300:1155-9. https://doi.org/10.1126/science.1082504
- Solesvik OV, Rofstad EK, Brustad T. Vascular changes in a human malignant melanoma xenograft following single-dose irradiation. Radiat Res 1984;98:115-28. https://doi.org/10.2307/3576056
- El Kaffas A, Giles A, Czarnota GJ. Dose-dependent response of tumor vasculature to radiation therapy in combination with Sunitinib depicted by three-dimensional high-frequency power Doppler ultrasound. Angiogenesis 2013;16:443-54. https://doi.org/10.1007/s10456-012-9329-2
- Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 2010;120:694-705. https://doi.org/10.1172/JCI40283
- Chen FH, Chiang CS, Wang CC, et al. Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors. Clin Cancer Res 2009;15:1721-9. https://doi.org/10.1158/1078-0432.CCR-08-1471
- Cramer W. Experimental observations on the therapeutic action of radium. In: The 10th Scientific Report on Imperial Cancer Research Fund. London: The Fund; 1932. p. 95-123.
- Lasnitzki I. A quantitative analysis of the direct and indirect action of X radiation on malignant cells. Br J Radiol 1947;20: 240-7. https://doi.org/10.1259/0007-1285-20-234-240
- Merwin R, Algire GH, Kaplan HS. Transparent-chamber observations of the response of a transplantable mouse mammary tumor to local roentgen irradiation. J Natl Cancer Inst 1950;11:593-627.
- Finkelstein SE, Timmerman R, McBride WH, et al. The confluence of stereotactic ablative radiotherapy and tumor immunology. Clin Dev Immunol 2011;2011:439752.
- McBride WH, Schaue D. In situ tumor ablation with radiation therapy: its effect on the tumor microenvironment and antitumor immunity. In: Keisari Y, editor. Tumor ablation: effects on systemic and local anti-tumor immunity and on other tumormicroenvironment interactions. New York, NY: Springer; 2013. p. 109-19.
- Kaur P, Asea A. Radiation-induced effects and the immune system in cancer. Front Oncol 2012;2:191.
- Ahmed MM, Guha C, Hodge JW, Jaffee E. Immunobiology of radiotherapy: new paradigms. Radiat Res 2014;182:123-5. https://doi.org/10.1667/RR13849.1
- Matsumura S, Wang B, Kawashima N, et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol 2008;181:3099-107. https://doi.org/10.4049/jimmunol.181.5.3099
- Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, Lord EM. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol 2005;174:7516-23. https://doi.org/10.4049/jimmunol.174.12.7516
- Lee Y, Auh SL, Wang Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 2009;114:589-95. https://doi.org/10.1182/blood-2009-02-206870
- Seung SK, Curti BD, Crittenden M, et al. Phase 1 study of stereotactic body radiotherapy and interleukin-2: tumor and immunological responses. Sci Transl Med 2012;4:137ra74.
- Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 2012;366:925-31. https://doi.org/10.1056/NEJMoa1112824
- Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys 2004; 59:242-9. https://doi.org/10.1016/j.ijrobp.2004.01.004
- Jeong JH, Park IW, Kang MA, Kim MS, Song CW. Effect of highdose hypofractionated irradiation (SBRT/SRS) on cell cycle progression [abstract]. In: 61th Radiation Research Society Annual Meeting; 2015 Sep 19-22; Weston, FL. Abstract no. PS1-24.
- Park H, Lyons JC, Griffin RJ, Lim BU, Song CW. Apoptosis and cell cycle progression in an acidic environment after irradiation. Radiat Res 2000;153:295-304. https://doi.org/10.1667/0033-7587(2000)153[0295:AACCPI]2.0.CO;2
- Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 2008;18:234-9. https://doi.org/10.1016/j.semradonc.2008.04.004
- Kirkpatrick JP, Meyer JJ, Marks LB. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 2008;18:240-3. https://doi.org/10.1016/j.semradonc.2008.04.005
Cited by
- Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma vol.11, pp.None, 2015, https://doi.org/10.1186/s13014-016-0597-7
- Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis vol.22, pp.30, 2016, https://doi.org/10.3748/wjg.v22.i30.6851
- Stereotactic Body Radiotherapy for Oligometastasis : Opportunities for Biology to Guide Clinical Management vol.22, pp.4, 2015, https://doi.org/10.1097/ppo.0000000000000202
- Quality assurance for a multicenter Phase II study of stereotactic ablative radiotherapy for hepatocellular carcinoma ≤5 cm: a planning dummy run vol.47, pp.6, 2015, https://doi.org/10.1093/jjco/hyw156
- Spine Metastasis Practice Patterns among Korean, Chinese, and Japanese Radiation Oncologists: A Multinational Online Survey Study vol.58, pp.1, 2015, https://doi.org/10.1093/jrr/rrw089
- Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report vol.10, pp.None, 2015, https://doi.org/10.2147/ott.s138595
- Stereotactic spine radiosurgery: Review of safety and efficacy with respect to dose and fractionation vol.8, pp.1, 2017, https://doi.org/10.4103/2152-7806.200581
- Clinical Outcomes of Salvage Chemoradiotherapy for Locally Recurrent Biliary Tract Cancer vol.103, pp.4, 2015, https://doi.org/10.5301/tj.5000666
- Anatomic and functional imaging in the diagnosis of spine metastases and response assessment after spine radiosurgery vol.42, pp.1, 2015, https://doi.org/10.3171/2016.9.focus16350
- Effects of Intratympanic Dexamethasone on High-Dose Radiation Ototoxicity In Vivo vol.38, pp.2, 2015, https://doi.org/10.1097/mao.0000000000001289
- Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors vol.35, pp.2, 2015, https://doi.org/10.3857/roj.2017.00024
- Role of HIF-1α in response of tumors to a combination of hyperthermia and radiation in vivo vol.34, pp.3, 2015, https://doi.org/10.1080/02656736.2017.1335440
- Feasibility of split-course stereotactic ablative radiotherapy for oligometastases vol.48, pp.6, 2018, https://doi.org/10.1093/jjco/hyy062
- The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules vol.11, pp.None, 2015, https://doi.org/10.1177/1179064418761639
- Radiation therapy-induced metastasis: radiobiology and clinical implications vol.35, pp.4, 2015, https://doi.org/10.1007/s10585-017-9867-5
- Vertebral Compression Fracture After Spine Stereotactic Body Radiation Therapy: A Review of the Pathophysiology and Risk Factors vol.83, pp.3, 2015, https://doi.org/10.1093/neuros/nyx493
- Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer vol.151, pp.2, 2018, https://doi.org/10.1016/j.ygyno.2018.08.029
- Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6 + cancer cell and macrophage polarization vol.9, pp.1, 2018, https://doi.org/10.1038/s41467-018-07470-w
- A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma vol.13, pp.1, 2015, https://doi.org/10.1186/s13014-018-0992-3
- From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC vol.2019, pp.None, 2015, https://doi.org/10.1155/2019/3267409
- Maximum standardized uptake value at pre-treatment PET in estimating lung cancer progression after stereotactic body radiotherapy vol.37, pp.1, 2019, https://doi.org/10.3857/roj.2019.00010
- The Reciprocity between Radiotherapy and Cancer Immunotherapy vol.25, pp.6, 2015, https://doi.org/10.1158/1078-0432.ccr-18-2581
- Twice-daily Radiation for Metastatic Malignant Melanoma: A Different Approach Resulting in a Significant Response vol.11, pp.3, 2015, https://doi.org/10.7759/cureus.4161
- Neuroimaging and Stereotactic Body Radiation Therapy (SBRT) for Spine Metastasis vol.28, pp.2, 2015, https://doi.org/10.1097/rmr.0000000000000199
- Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT) vol.16, pp.None, 2015, https://doi.org/10.1016/j.ctro.2019.01.003
- Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer vol.16, pp.None, 2015, https://doi.org/10.1016/j.ctro.2019.03.001
- Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies vol.11, pp.7, 2019, https://doi.org/10.3390/cancers11070976
- Reoxygenation and Repopulation of Tumor Cells after Ablative Hypofractionated Radiotherapy (SBRT and SRS) in Murine Tumors vol.192, pp.2, 2015, https://doi.org/10.1667/rr15346.1
- Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients vol.145, pp.10, 2019, https://doi.org/10.1007/s00432-019-02983-3
- Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy vol.79, pp.22, 2015, https://doi.org/10.1158/0008-5472.can-19-1323
- Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors vol.9, pp.1, 2015, https://doi.org/10.1038/s41598-019-51900-8
- Targeted next-generation DNA sequencing identifies Notch signaling pathway mutation as a predictor of radiation response vol.95, pp.12, 2019, https://doi.org/10.1080/09553002.2019.1665212
- Advances in Radiobiology of Stereotactic Ablative Radiotherapy vol.10, pp.None, 2015, https://doi.org/10.3389/fonc.2020.01165
- A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy vol.126, pp.2, 2015, https://doi.org/10.1002/cncr.32502
- Clinical utilization of radiation therapy in Korea, 2016 vol.61, pp.2, 2015, https://doi.org/10.1093/jrr/rrz095
- Optimization of irradiation interval for fractionated stereotactic radiosurgery by a cellular automata model with reoxygenation effects vol.65, pp.8, 2015, https://doi.org/10.1088/1361-6560/ab7974
- Imaging response assessment following stereotactic body radiotherapy for solid tumour metastases of the spine: Current challenges and future directions vol.64, pp.3, 2015, https://doi.org/10.1111/1754-9485.13032
- Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol vol.10, pp.9, 2015, https://doi.org/10.1136/bmjopen-2020-038391
- Acoustic neuroma presenting as a hypnic headache vol.14, pp.3, 2015, https://doi.org/10.1136/bcr-2020-235830
- Brain Metastasis Response to Stereotactic Radio Surgery: A Mathematical Approach vol.9, pp.7, 2015, https://doi.org/10.3390/math9070716
- Hypofractionation in Early Stage Non-Small Cell Lung Cancer vol.31, pp.2, 2015, https://doi.org/10.1016/j.semradonc.2020.11.003
- First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias vol.11, pp.1, 2015, https://doi.org/10.1038/s41598-021-89857-2
- Improved cellular automata model shows that indirect apoptotic cell death due to vascular damage enhances the local control of tumors by single fraction high-dose irradiation vol.8, pp.1, 2022, https://doi.org/10.1088/2057-1976/ac4466